Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert L Talbert

Showing results (1-10 of 52) with videos related to

Pageof 6
Sort By:
Pharmacotherapy|July 26, 2006
The challenge of blood pressure management in neurologic emergenciesRobert L Talbert
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|July 2, 2008
Overview of advances in cardiovascular disease treatment and prevention: the evolving role of antiplatelet therapyRobert L Talbert
Pharmacotherapy|October 7, 2014
In Memory of Charles Anthony Walton, Ph.D., FCCP 1926-2014Robert L Talbert
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|August 7, 2003
Role of the National Cholesterol Education Program Adult treatment panel III guidelines in managing dyslipidemiaRobert L Talbert,
Journal of the American Pharmacists Association : Japha|November 25, 2003
Treatment of acute and chronic heart failureRobert L Talbert
Heart Failure Reviews|November 2, 2004
Pharmacokinetics and pharmacodynamics of beta blockers in heart failureRobert L Talbert
The American Journal of Managed Care|September 21, 2002
New therapeutic options in the National Cholesterol Education Program Adult Treatment Panel IIIRobert L Talbert
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|August 7, 2003
Niacin in the treatment of dyslipidemia: insight from Adult Treatment Panel III. IntroductionRobert L Talbert,
Journal of the American Pharmacists Association : Japha|September 14, 2010
Role of antihypertensive therapy with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers in combination with calcium channel blockers for stroke preventionRobert L Talbert
Journal of the American Pharmacists Association : Japha|August 18, 2006
Safety issues with statin therapyRobert L Talbert
Pageof 6

Showing results (1-10 of 52) with videos related to

Sort By:
Pageof 6
Pharmacotherapy|July 26, 2006
The challenge of blood pressure management in neurologic emergenciesRobert L Talbert
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|July 2, 2008
Overview of advances in cardiovascular disease treatment and prevention: the evolving role of antiplatelet therapyRobert L Talbert
Pharmacotherapy|October 7, 2014
In Memory of Charles Anthony Walton, Ph.D., FCCP 1926-2014Robert L Talbert
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|August 7, 2003
Role of the National Cholesterol Education Program Adult treatment panel III guidelines in managing dyslipidemiaRobert L Talbert,
Journal of the American Pharmacists Association : Japha|November 25, 2003
Treatment of acute and chronic heart failureRobert L Talbert
Heart Failure Reviews|November 2, 2004
Pharmacokinetics and pharmacodynamics of beta blockers in heart failureRobert L Talbert
The American Journal of Managed Care|September 21, 2002
New therapeutic options in the National Cholesterol Education Program Adult Treatment Panel IIIRobert L Talbert
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|August 7, 2003
Niacin in the treatment of dyslipidemia: insight from Adult Treatment Panel III. IntroductionRobert L Talbert,
Journal of the American Pharmacists Association : Japha|September 14, 2010
Role of antihypertensive therapy with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers in combination with calcium channel blockers for stroke preventionRobert L Talbert
Journal of the American Pharmacists Association : Japha|August 18, 2006
Safety issues with statin therapyRobert L Talbert
Pageof 6